In this series of Translational Lung Cancer Research, a group of renowned world experts presents the comprehensive and timely review of state-of-the-art radiation therapy in lung cancer and other thoracic malignancies.
Stereotactic radiotherapy for early stage non-small cell lung cancer: current standards and ongoing research
Preoperative and postoperative radiotherapy (RT) for non-small cell lung cancer: still an open question
Stage III N2 non-small cell lung cancer treatment: decision-making among surgeons and radiation oncologists
Concurrent chemoradiotherapy for stage III non-small-cell lung cancer: recent progress and future perspectives (a narrative review)
Combining radiotherapy with targeted therapies in non-small cell lung cancer: focus on anti-EGFR, anti-ALK and anti-angiogenic agents
An overview of the published and running randomized phase 3 clinical results of radiotherapy in combination with immunotherapy
The series “Radiotherapy in thoracic malignancies” was commissioned by the editorial office, Translational Lung Cancer Research without any sponsorship or funding. Jacek Jassem and Rafał Dziadziuszko served as the unpaid Guest Editors for the series.